Directa Plus PLC Grant of Italian Filtration Patent
June 22 2022 - 1:00AM
RNS Non-Regulatory
TIDMDCTA
Directa Plus PLC
22 June 2022
22 June 2022
Directa Plus plc
("Directa Plus" or the "Company")
Grant of Italian Patent for Filtration Applications
Directa Plus (AIM: DCTA), a leading producer and supplier of
graphene nanoplatelets based products for use in consumer and
industrial markets, announces that the Company has been granted an
Italian patent covering the use of the Company's G+(R) pristine
graphene nanoplatelets applied to textile substrates for high
bacterial filtration efficiency media for filtration applications .
The priority date for the patent is 25 May 2020.
G+(R) applied to textile substrates provides proven
antibacterial and antiviral (including anti-SARS-CoV-2)
performance. The target filtration market applications cover both
medical and industrial use. Directa Plus started work on air
filtration in 2020 with a signature project that successfully
supplied face masks with anti-SARS-CoV-2 protection. This work led
quickly into exploring industrial filtration applications starting
with the automotive and HVAC (heating, ventilation and air
conditioning) markets. Directa Plus, as already announced, has
partnered with a leading worldwide supplier of non-woven textile
materials to develop a suite of new products for automotive and
industrial applications based on the antimicrobial properties
(antibacterial and antiviral), thermal comfort and electrical
conductivity properties of G+(R) enhanced fabrics.
Following the grant of the patent, Directa Plus's IP portfolio
comprises 20 patent families with 73 patents granted and 28 patents
pending.
Commenting, Giulio Cesareo, Founder and CEO of Directa Plus,
said: "The grant of a patent for a new market vertical demonstrates
the speed with which we can enter existing high potential markets
to supply innovative new products. The international filtration
markets are large and we believe that there will be significant
demand for proven antimicrobial products which we aim to launch
quickly with our industrial partners."
For further information please visit
http://www.directa-plus.com/ or contact:
Directa Plus plc +39 02 36714458
Giulio Cesareo, CEO / Giorgio Bonfanti,
CFO
Cenkos Securities plc (Nominated Adviser
and Joint Broker) +44 131 220 6939
Neil McDonald / Adam Rae
Singer Capital Markets (Joint Broker) +44 20 7496 3069
Rick Thompson / Phil Davies
Tavistock (Financial PR and IR) +44 20 7920 3150
Simon Hudson / Heather Armstrong
About Directa Plus
Directa Plus (www.directa-plus.com) is one of the largest
producers and suppliers of graphene-based products for use in
consumer and industrial markets. The Company's graphene
manufacturing capability uses proprietary patented technology based
on a plasma super expansion process. Starting from natural
graphite, each step of Directa Plus' production process -
expansion, exfoliation and drying - creates graphene-based
materials and hybrid graphene materials ready for a variety of uses
and available in various forms such as powder, liquid and
paste.
This proprietary production process uses a physical process,
rather than a chemical process, to process graphite into pristine
graphene nanoplatelets, which enables Directa Plus to offer a
sustainable, non-toxic product, without unwanted by-products.
Directa Plus' products are made of hybrid graphene materials and
graphene nano-platelets. The products (marketed as G+(R)) have
multiple applications due to its properties. These G+(R) products
can be categorised into various families, with different products
being suitable for specific practical applications.
Directa Plus was established in 2005 and is based in Lomazzo
(Como, Italy) and has been listed on the AIM market of the London
Stock Exchange since May 2016. The Company holds the Green Economy
Mark from London Stock Exchange which recognises companies that
contribute to the global green economy.
-ends-
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAFBMATMTITBTT
(END) Dow Jones Newswires
June 22, 2022 02:00 ET (06:00 GMT)
Directa Plus (LSE:DCTA)
Historical Stock Chart
From Apr 2024 to May 2024
Directa Plus (LSE:DCTA)
Historical Stock Chart
From May 2023 to May 2024